# Paul Lelieveld

> Paul Lelieveld is a seed investor at Meneldor (Eindhoven) backing Biotechnology and Biopharma. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Meneldor](https://shizune.co/investors/profile/meneldor)
- Location: Eindhoven, The Netherlands
- Total investments: 5
- Last investment: Nov 2022
- Lead investor: 60%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/paul-lelieveld-002b05/

Paul Lelieveld is a Founding Partner at Meneldor.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Biopharma | 1 | 20% |
| Consulting | 1 | 20% |
| Health Care | 1 | 20% |
| Therapeutics | 1 | 20% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 20% |
| Series A | 1 | 20% |
| Debt Financing | 1 | 20% |
| Convertible Note | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Norway | 1 | 20% |
| Germany | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hemispherian | Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer. | $3M | Series A | Nov 24, 2022 |  |
| Hemispherian | Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer. | $1.3M | Seed | May 03, 2022 |  |
| Hemispherian | Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer. | $1.3M | Seed | May 03, 2022 |  |
| Hemispherian | Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer. |  | Convertible Note | Apr 01, 2022 |  |
| Atriva Therapeutics | Atriva Therapeutics is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections. Atriva Therapeutics completed preclinical development of ATR-002 and recently filed a request for scientific advice from a European regulatory authority to provide guidance on the executed preclinicaldevelopment program and the planned ATR-002 Phase I study in healthy volunteers. | $10.1M | Debt Financing | Aug 12, 2020 |  |

5 of 5 investments shown.

## Co-investors
- [BIF Partners](https://shizune.co/investors/profile/b-i-f) — VC Fund, 2 deals together
- [Kvantia](https://shizune.co/investors/profile/anden%C3%A6sgruppen-andenaes-group) — VC Fund, 1 deal together
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund, 1 deal together
- [Kistefos Venture Capital](https://shizune.co/investors/profile/kirkland-ellis) — VC Fund, 1 deal together
- [Meneldor](https://shizune.co/investors/profile/meneldor) — VC Fund, 1 deal together

## About Meneldor

VC Fund · Druten, The Netherlands

Meneldor is a biopharmaceutical investment company .

1 contacts available at Meneldor.

| Name | Title | Profile |
| --- | --- | --- |
| Paul Lelieveld | Founding Partner | https://shizune.co/investors/profile/paul-lelieveld |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Paul Lelieveld invest in?

Paul Lelieveld invests primarily in Biotechnology, Biopharma and Consulting startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Paul Lelieveld last invest?

The most recent investment recorded for Paul Lelieveld closed in Nov 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co